Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.

<h4>Background</h4>Emerging data in chronic kidney disease (CKD) patients suggest that iron deficiency and higher circulating levels of erythropoietin (EPO) stimulate the expression and concomitant cleavage of the osteocyte-derived, phosphate-regulating hormone fibroblast growth factor 2...

Full description

Bibliographic Details
Main Authors: Michele F Eisenga, Maarten A De Jong, Peter Van der Meer, David E Leaf, Gerwin Huls, Ilja M Nolte, Carlo A J M Gaillard, Stephan J L Bakker, Martin H De Borst
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-06-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1002818

Internet

https://doi.org/10.1371/journal.pmed.1002818

Similar Items